Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum β-lactamases

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 6, 2008, Pages 1245-1251

  Jones, G Ll ^a   Warren, Rod E ^a   Skidmore, S J ^a   Davies, V A ^a   Gibreel, T ^b   Upton, M ^b  

^a ROYAL SHREWSBURY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Aac(6 ) Ib; ESBLs; Qnr

Indexed keywords

ACYLTRANSFERASE; AMIKACIN; AMINOGLYCOSIDE; BACTERIAL PROTEIN; BETA LACTAMASE CTX M 15; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; NORFLOXACIN; PROTEIN AAC 6 LB CR; PROTEIN QNR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; ESCHERICHIA COLI; GENOTYPE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PLASMID; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROTYPE; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; DNA FINGERPRINTING; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GREAT BRITAIN; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; QUINOLONES; SEROTYPING; URINARY TRACT INFECTIONS;

EID: 56649099255     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn406     Document Type: Article

References (28)

1. Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet 1998; 351: 797-9.
2. Tran JH, Jacoby GA. Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci USA 2002; 9: 5638-42.
3. Jacoby GA, Walsh KE, Mills DM et al. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob Agents Chemother 2006; 50: 1178-82.
4. Hata M, Suzuki M, Matsumoto M et al. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother 2005; 49: 801-3.
5. Wang M, Tran JH, Jacoby GA et al. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 2003; 47: 2242-8.
6. Robicsek A, Strahilevitz J, Jacoby GA et al. Fluoroquinolone-modifying enzyme: A new adaptation of a common aminoglycoside acetyltransferase. Nat Med 2006; 12: 83-8.
7. Boyd DA, Tyler S, Christianson S et al. Complete nucleotide sequence of a 92-kilobase plasmid harbouring the CTX-M-15 extended-spectrum β-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother 2004; 48: 3758-64.
8. Park CH, Robicsek A, Jacoby GA et al. Prevalence in the United States of aac(6′)-lb-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2006; 50: 3953-5.
9. Jiang Y, Zhou Z, Oian Y et al. Plasmid-mediated quinolone resistance determinants qnr and aac(6′)-lb-cr in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in China. J Antimicrob Chemother 2008; 61: 1003-6.
10. Canton R, Coque TM. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006; 9: 466-75.
11. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V et al. Intercontinental emergence of Escherichia coli clone 025:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61: 273-81.
12. Warren RE, Harvey G, Carr R et al. Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community. Clin Microbiol Infect 2008; 14 Suppl 1: 124-33.
13. Pitout JD, Wei Y, Church DL, et al. Surveillance for plasmid-mediated quinolone resistance determinants in Enterobacteriaceae-within the Calgary Health Region, Canada: The emergence of aac(6′)-lb-cr. J Antimicrob, Chemother 2008; 61 999-1002.
14. Livermore DM, Nichols T, Lamagni TL et al. Ciprofloxacin-resistant Escherichia coli in England: Increasingly prevalent and mostly from men. J Antimicrob Chemother 2003; 52: 1040-2.
15. Fallon D, Andrews N, Frodsham D et al. A comparison of the performance of commercially available chromogenic agars for the isolation and presumptive identification of organisms from urine. J Clin Pathol 2002; 55: 524-9.
16. Andrews JM. BSAC standardized disc susceptibility testing method (version 5). J Antimicrob Chemother 2006; 58: 511-29.
17. Livermore DM, Brown DFJ, Detection of β-lactamase-mediated resistance. J Antimicrob Chemother 2001; 48 Suppl 1: 59-64.
18. Karisik E, Ellington MJ, Pike R et al. Wide occurrence of the fluoroquinolone-modifying acetyltransferase gene aac(6′ -lb-cr in CTX-M-positive Escherichia coli from the United Kingdom. In: Abstracts of the Forty-sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, USA 2006. Abstract C2-110, p.104. American Society for Microbiology, Washington, DC, USA.
19. Cattoir V, Poirel L, Rotimi V et al. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 2007; 60: 394-7.
20. Karisik E, Underwood A, Ellington MJ et al. Complete nucleotide sequence of pEK499, a multidrug-resistance plasmid from the UK's most prevalent Escherichia coli strain with CTX-M-15 β-lactamase. In: Abstracts of the Seventeenth European Congress of Clinical Microbiology and Infectious Diseases, Munich, Germany, 2007. Abstract P864.
21. Machado E, Coque TM, Sousa JC et al. Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-producing Enterobacteriaceae strains containing the aac(6′)-lb-cr gene, which encodes an aminoglycoside- and fluoroquinoione-modifying enzyme. Antimicrob Agents Chemother 2006; 50: 3220-1.
22. Soge OO, Adeniyi BA, Roberts MC. New antibiotic resistance genes associated with CTX-M plasmids from uropathogenic Nigerian Klebsiella pneumoniae. J Antimicrob Chemother 2006;58: 1048-53.
23. Poirel L, Pitout JDD, Calvo L et al. In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum β-lactamase. Antimicrob Agents Chemother 2006; 50: 1525-7.
24. Rather PN, Munayyer H, Mann PA et al. Genetic analysis of bacterial acetyltransferases: Identification of amino acids determining the specificities of the aminoglycoside 6′-N-acetyltransferase lb and lla proteins. J Bacteriol 1992; 174: 3196-203.
25. Sompolinsky D, Nitzan Y, Tetry S et al. Integron-mediated ESBL resistance in rare serotypes of Escherichia coli causing infections in an elderly population of Israel. J Antimicrob Chemother 2005; 55: 119-22.
26. Cagnacci S, Gualco L, Debbia E et al. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups 025:H4-ST131 and 015:K52:H1 causing community-acquired uncomplicated cystitis. J Clin Microbiol 2008; 46: 2605-12.
27. Karisik E, Ellington MJ, Pike R et al. Molecular characterization of plasmids encoding CTX-M-15 β-lactamases from Escherichia coli strains in the United Kingdom. J Antimicrob Chemother 2006; 58 665-8.
28. Orskov I, Orskov F, Jann B et al. Serology, chemistry, and genetics of O and K antigens of Escherichia coli. Bacteriol Rev 1977; 41: 667-710.